Philip la Fleur is a pharmacist/epidemiologist with over 20 years of experience in pharmaceuticals, health technology assessment and clinical research and he has worked in a wide variety of therapeutic areas. He was recently a consultant to the Kazakhstan Ministry of Health within the Health Sector Technology Transfer and Institutional Reform (World Bank) Project and was Deputy Director, Center for Life Sciences, Nazarbayev University. He has contributed to over 90 systematic clinical reviews of new pharmaceuticals with Canada’s health technology assessment agency, CADTH. He has also held research positions in several pharmaceutical companies, including Abbott, Amgen and GlycoDesign. His current research interest is related to the development the role of the clinician-researcher within Kazakhstan’s healthcare system.